Authors:
DELAISI B
GROSSKOPF C
REIGNAULT E
GOEHRS JM
NAVARRO J
Citation: B. Delaisi et al., EPIDEMIOLOGIC INTERNATIONAL REGISTRY OF C YSTIC-FIBROSIS - COMPARISONOF FRENCH DATA WITH EUROPEAN DATA FOR 1995, Archives de pediatrie, 5(4), 1998, pp. 384-388
Authors:
GEHANNO P
NGUYEN L
DERRIENNIC M
PICHON F
GOEHRS JM
BERCHE P
Citation: P. Gehanno et al., PATHOGENS ISOLATED DURING TREATMENT FAILURES IN OTITIS, The Pediatric infectious disease journal, 17(10), 1998, pp. 885-890
Authors:
HENRY B
AUSSAGE P
GROSSKOPF C
DEFONTBRUNE S
GOEHRS JM
Citation: B. Henry et al., MEASURING QUALITY-OF-LIFE IN CHILDREN WITH CYSTIC-FIBROSIS - THE CYSTIC-FIBROSIS QUESTIONNAIRE (CFQ), Quality of life research, 6(7-8), 1997, pp. 148-148
Authors:
AUTRET E
RADAL M
JONVILLEBERA AP
GOEHRS JM
Citation: E. Autret et al., ISOTRETINOIN IN CHILDBEARING WOMEN - LACK OF COMPLIANCE WITH WARNINGS, Annales de dermatologie et de venereologie, 124(8), 1997, pp. 518-522
Authors:
BOISSEL JP
PERRET L
BOUVENOT G
CASTAIGNE A
GERARDCOUE MJ
MAILLERE P
MISMETTI P
VRAY M
AVOUAC B
BEGAUD B
CAULIN C
CHARPAK Y
CHAUMETRIFFAUD P
COSTAGLIOLA D
DEGOS F
DESTORS JM
DOYON F
FAGNANI F
GIRI I
GIRRE JP
GOEHRS JM
KHER A
MOCCATTI D
MUNOZ A
DECURZON AP
PLETAN Y
ROY P
VASMANT D
WAJMAN A
Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285
Authors:
AUTRET E
REBOULMARTY J
HENRYLAUNOIS B
LABORDE C
COURCIER S
GOEHRS JM
LANGUILLAT G
LAUNOIS R
Citation: E. Autret et al., EVALUATION OF IBUPROFEN VERSUS ASPIRIN AND PARACETAMOL ON EFFICACY AND COMFORT IN CHILDREN WITH FEVER, European Journal of Clinical Pharmacology, 51(5), 1997, pp. 367-371
Authors:
DOHIN E
ROUSSELLE B
PICHOT L
LOIZEAU S
ANDRIAMANAMIHAJA M
GOEHRS JM
Citation: E. Dohin et al., SAQUINAVIR IN THE TREATMENT OF HIV-INFECTION - PATTERNS OF USE IN THEFRENCH COMPASSIONATE USE PROGRAM, JUNE 1996, AIDS, 10, 1996, pp. 44-44
Authors:
MARANINCHI D
BARBET J
BATTAIS J
EMILIE D
GOEHRS JM
GUINOT P
MANNONI P
MEYER P
ROMETLEMONNE JL
TROUVIN JH
CALVO F
GALANAUD P
GOUYETTE A
JULOU CL
MARCEL T
MOREL A
QUENTINMILLET MJ
SCHATZ C
WIJDENES J
Citation: D. Maraninchi et al., WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN, Therapie, 51(4), 1996, pp. 431-433
Authors:
LAUNOIS R
HENRY B
MARTY JR
GERSBERG M
LASSALE C
BENOIST M
GOEHRS JM
Citation: R. Launois et al., CHEMONUCLEOLYSIS VERSUS SURGICAL DISKECTOMY FOR SCIATICA SECONDARY TOLUMBAR DISC HERNIATION - A COST AND QUALITY-OF-LIFE EVALUATION, PharmacoEconomics, 6(5), 1994, pp. 453-463
Authors:
BOUVENOT G
TEULEESPIE M
ABITEBOUL M
ALT M
AVOUAC B
BANNWARTH B
BOUREAU F
BRUXELLE J
DAVID N
DUVALDESTIN P
ESCHWEGE E
GOEHRS JM
LEVY M
NGUYENTRAMOND A
Citation: G. Bouvenot et al., ANALYSIS AND EVALUATION OF STRATEGIES FOR MEDICAL-TREATMENT OF PAIN, Therapie, 49(3), 1994, pp. 235-238
Authors:
AUTRET E
BREART G
JONVILLE AP
COURCIER S
LASSALE C
GOEHRS JM
Citation: E. Autret et al., COMPARATIVE EFFICACY AND TOLERANCE OF IBUPROFEN SYRUP AND ACETAMINOPHEN SYRUP IN CHILDREN WITH PYREXIA ASSOCIATED WITH INFECTIOUS-DISEASES AND TREATED WITH ANTIBIOTICS, European Journal of Clinical Pharmacology, 46(3), 1994, pp. 197-201
Citation: E. Vignon et al., FLURBIPROFEN SUSTAINED-RELEASE 200 MG AND KETOPROFEN SUSTAINED-RELEASE 200 MG IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Revue du rhumatisme, 60(7-8), 1993, pp. 530-535